We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Bruker Daltonics and HealthLinx Expand Biomarker Discovery Collaboration

The companies with further develop biomarkers for a number of pregnancy complications.
News

Rules-Based Medicine and Multiplex Biosciences Merge

Merger extends R&D capabilities, product expertise and expands customer base.
News

onCore UK Licenses LabVantage's Sapphire™ BioBanking Solution to Support its Ambitious Cancer Biosample Resource

onCore UK will create and run a national biosample resource, collecting and storing tissue and blood samples donated by patients.
News

Kimball Genetics Launches the Warfarin Sensitivity DNA Test for Research

The Warfarin Sensitivity DNA Test determines the presence of specific variations in the CYP2C9 and VKORC1 genes that confer sensitivity to warfarin.
News

Genzyme Launches Cystic Fibrosis Gene Sequencing Test

CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
News

Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer

The trial will enroll patients with previously untreated, advanced or recurrent pancreatic cancer and a mutation in the BRCA2 gene.
News

TranSenda Announces Membership in BioIT Alliance

As a member of the BioIT Alliance, TranSenda will work in partnership with other science and technology industry leaders.
News

AviaraDx Announces Publication of Study with Baylor College of Medicine

The study demonstrates a two-gene ratio is a prognostic indicator of breast cancer recurrence risk.
News

Genomic Tests Guide Choice of Chemotherapy in Cancer Patients

The tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy.
News

Xenomics Announces Development of a Method for Isolation of Cell-Free Nucleic Acids From Urine

Prototype research kits approach commercialization phase and target the growing field of genomic-based molecular diagnostics.
Advertisement